CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Delisting notice
- 4 Open-market sale Chief R&D Officer sold 9,791 shares at $0.72 ($7,050)
- 4 Open-market sale Chief Legal Officer sold 7,543 shares at $0.72 ($5,431)
- 4 Open-market sale President & CEO sold 20,361 shares at $0.72 ($14,660)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Agreement ended · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure · Other events
Page 15 of 100 · 1,982 filings